Mr Sanjay Purkayastha
BSc MBBS MD FRCS
Laparoscopic, General and Bariatric Surgeon
Private Medical Care:
General & gastroenterological surgery
Bariatric / weight loss surgery
Emergency abdominal conditions / surgery
Sir, Further to your report “Johnson to launch war on fat after virus scare” (May 15), obesity is a disease, not a choice. There is now enormous data in scientific literature to implicate genetics, metabolism, mental health, education, social deprivation, access to healthcare and other factors beyond an individual’s control in the complex causes of this disease.
Bariatric surgery is known to provide up to a 40 per cent reduction in all-cause mortality in patients suffering from severe, complex obesity. It reduces heart attacks, strokes, cancer risk and the risk of diabetes, and can even reverse the end-organ damage from chronic diseases such as diabetes.
Understandably, most bariatric surgery services globally have shut during the pandemic. However, rather worryingly, plans to restart them are all up in the air. We will undoubtedly need to develop newer ways to manage and mitigate risks associated with the pandemic. Several strategies, such as pre-operative isolation, testing, personal protective equipment for staff and shorter hospital stays, are already being piloted around the world.
Boris Johnson’s support sounded very much like a call to arms in this battle to restart (and provide improved access to) bariatric surgery.
Sanjay Purkayastha, clinical senior lecturer in bariatric surgery, Imperial College London; Philip Schauer, professor of metabolic surgery, Louisiana State University; Paulina Salminen, professor of surgery, Turku University Hospital; Almino Ramos, medical director, Gastro-Obeso-Centre Metabolical Optimisation Institute, Sao Paulo; Kamal Mahawar, consultant surgeon, Sunderland Royal Hospital
Mr Sanjay Purkayastha, Clinical Senior Lecturer in Bariatric Surgery and Consultant Surgeon for the Department, has worked with fashion retailer Burberry to supply St Mary’s Hospital with one tonne of surgical gowns.
PanSurg is a global initiative to deliver education and research to the frontline during the COVID-19 pandemic.
The obesity pandemic has been a burden globally for decades. The current COVID-19 pandemic has superimposed its morbidity, especially on those with the disease of obesity and obesity-related comorbidities such as type 2 diabetes.
Medtronic (NYSE:MDT) announced today that it has acquired Digital Surgery (London), a privately-held pioneer in surgical artificial intelligence, data and analytics, and digital education and training.
Financial terms of the deal were not disclosed.
Medtronic and Digital Surgical expect to co-develop systems providing AI and data analytics for laparoscopic and robot-assisted surgery.
Dr. Sanjay Purkayastha at Imperial College performs a bariatric procedure, demonstrating the clinical efficacy of Digital Surgery's AI and computer vision platform. Source: Business Wire
This live webinar that was hosted at Digital Surgery labs in London. Dr. Sanjay Purkayastha talked about the use of digital technologies in the operating room and the benefits of digitizing surgical record-keeping to improve efficiency, patient safety, training, and standardization.
Dr Purkayastha talks about the referral guidelines in the UK for weight loss surgery.
American Heart Association Scientific Sessions, Oral Presentation 335
Obese people who undergo weight-reduction surgery live longer than obese people who do not have surgery, according to new research.
Those who have weight-loss surgery are also less likely to have a clot-related stroke than those who don’t have surgery.
Embargoed until 4 a.m. CT/5 a.m. ET Monday, Nov. 11, 2019
DALLAS, Nov. 11, 2019 — Obese patients who undergo weight-reduction surgery live longer and are less likely to experience a clot-caused stroke than those who do not, according to preliminary research to be presented at the American Heart Association’s Scientific Sessions 2019 — November 16-18 in Philadelphia. The Association’s Scientific Sessions is an annual, premier global exchange of the latest advances in cardiovascular science for researchers and clinicians.
Please note, most insurance policies in the UK do not cover weight-loss surgery. However, we will do our utmost to provide the best package for you should you choose to have your surgery with us.